LILRB1 and Miyoshi myopathy: As discussed earlier in this review, recent studies have shown that LILRB1, a key regulator of cholesterol metabolism, protects MM cells from ferroptosis by maintaining cholesterol homeostasis [47], while expression of SREBPs are associated with decreased ferroptosis sensitivity in other malignancies [47, 73, 95].